Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
952
Employees952
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
952
Employees952

NVAX Key Statistics

Market cap
1.30B
Market cap1.30B
Price-Earnings ratio
4.53
Price-Earnings ratio4.53
Dividend yield
Dividend yield
Average volume
5.12M
Average volume5.12M
High today
$8.33
High today$8.33
Low today
$7.73
Low today$7.73
Open price
$7.77
Open price$7.77
Volume
5.45M
Volume5.45M
52 Week high
$10.64
52 Week high$10.64
52 Week low
$5.01
52 Week low$5.01

Stock Snapshot

Novavax(NVAX) stock is priced at $8.00, giving the company a market capitalization of 1.3B. It carries a P/E multiple of 4.53.

On 2026-01-18, Novavax(NVAX) stock traded between a low of $7.73 and a high of $8.33. Shares are currently priced at $8.00, which is +3.5% above the low and -4.0% below the high.

Novavax(NVAX) shares are trading with a volume of 5.45M, against a daily average of 5.12M.

In the last year, Novavax(NVAX) shares hit a 52-week high of $10.64 and a 52-week low of $5.01.

In the last year, Novavax(NVAX) shares hit a 52-week high of $10.64 and a 52-week low of $5.01.

NVAX News

Simply Wall St 2d
Is Novavax's Partner-Led Shift With Sanofi Quietly Rewriting Its Risk-Reward Equation?

At the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, Novavax outlined a partner-led operating model centered on its Matrix-M adjuvant platform...

Is Novavax's Partner-Led Shift With Sanofi Quietly Rewriting Its Risk-Reward Equation?
Simply Wall St 5d
Improved Revenues Required Before Novavax, Inc. Stock's 32% Jump Looks Justified

Novavax, Inc. ( ) shareholders are no doubt pleased to see that the share price has bounced 32% in the last month, although it is still struggling to make up re...

Improved Revenues Required Before Novavax, Inc. Stock's 32% Jump Looks Justified
TipRanks 6d
Novavax Outlines New Growth Strategy and Partnerships

Claim 70% Off TipRanks Premium Novavax ( (NVAX) ) has provided an announcement. Novavax plans to provide investors with strategic and business updates on Janu...

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
20%
Sell
30%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .